Therefore, it is difficult to interpret the effects of overexpression of the catalytic subunit of PP2A itself on cell viability, because it is unknown, which specific PP2A interprotein or intraprotein complexes are involved in its tumour suppressor function after being released from I2PP2A/SET in response to FTY720. The gene discussed is SET; the disease is neoplasm.